Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 20, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Breast CancerBreast Implant; Complications, Infection or Inflammation
Interventions
DEVICE

Acellular Dermal Matrix

Acellular dermal matrix will surgically implanted around the tissue expanders in patients in the ADM cohort.

PROCEDURE

Reconstruction without ADM

Acellular dermal matrix will not be surgically implanted around the tissue expanders in patients in the control cohort.

Trial Locations (1)

90095

RECRUITING

University of California Los Angeles, Los Angeles

All Listed Sponsors
collaborator

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Yale University

OTHER

collaborator

University of California, Davis

OTHER

collaborator

University of Utah

OTHER

collaborator

University of California, San Francisco

OTHER

lead

University of California, Los Angeles

OTHER